IDEAYA Biosciences (IDYA) Non Operating Income (2019 - 2026)

IDEAYA Biosciences (IDYA) has 8 years of Non Operating Income data on file, last reported at $10.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 18.07% year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at $43.4 million (down 18.5% YoY), and the FY2025 full-year result was $45.6 million, down 13.11% from the prior year.
• Non Operating Income declined to $10.0 million in Q1 2026, from $11.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $15.1 million in Q3 2024 to a low of $207000.0 in Q1 2022.
• A 5-year average of $7.8 million and a median of $10.0 million in 2026 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income surged 1328.03% in 2022 and fell 28.4% in 2025, its largest moves.
• Tracing IDYA's Non Operating Income over 5 years: stood at $2.2 million in 2022, then surged by 255.13% to $8.0 million in 2023, then surged by 73.65% to $13.8 million in 2024, then decreased by 18.29% to $11.3 million in 2025, then slipped by 11.44% to $10.0 million in 2026.
• Business Quant data shows IDYA's Non Operating Income at $10.0 million in Q1 2026, $11.3 million in Q4 2025, and $10.8 million in Q3 2025.